Onterris Earnings Call Transcripts
Fiscal Year 2026
-
Q2 revenue fell to $186.7M due to low emergency response activity, but EBITDA margins improved to 17.1% on cost optimization. Full-year guidance was lowered, yet profitability and cash flow remain strong. The Board has launched a strategic review of all alternatives.
-
The company is targeting $1 billion in revenue within 3-4 years, driven by strong organic growth, high client retention, and expansion in high-margin services like water treatment. Recent rebranding and segment consolidation aim to enhance operational efficiency and cross-selling, while ongoing R&D investment and a robust IP portfolio support continued market share gains.
-
Q1 revenue declined year-over-year due to weather and lower emergency response, but margins and adjusted EBITDA exceeded expectations. Full-year guidance remains unchanged, with significant revenue and EBITDA growth expected in the second half as delayed projects are executed.
Fiscal Year 2025
-
Record 2025 results featured 19.3% revenue growth and 21.3% EBITDA growth, with strong organic performance and robust cash flow. 2026 guidance targets up to $900 million in revenue and continued margin expansion, supported by resilient demand, cross-selling, and new growth drivers in water technology and AI-related services.
-
Record Q3 and year-to-date results driven by strong organic growth, margin expansion, and robust demand across all segments. 2025 guidance was raised, with continued optimism for 2026, supported by strategic capital allocation, exit from renewables, and a planned restart of acquisitions.
-
Record Q2 results featured 35% revenue and 70% adjusted EBITDA growth, driven by strong organic performance and emergency response work. Guidance for 2025 was raised, with continued margin expansion, robust cash flow, and a simplified balance sheet supporting long-term growth.
-
Integrated environmental services are driving strong organic growth, with a focus on cross-selling to a diverse customer base and minimal federal revenue exposure. Regulatory clarity, especially around PFAS, and increased industrial activity are creating tailwinds, while operational improvements and a clean balance sheet position the company for continued margin and cash flow gains.
-
Record Q1 revenue and EBITDA were driven by strong organic growth and segment performance, leading to raised EBITDA guidance for 2025. PFAS-related services and robust private sector demand continue to support growth, while capital allocation focuses on deleveraging and stock repurchases.
-
Operations remain stable despite recent events, with no material impact from regulatory or political changes. PFAS regulations and state-level activity are driving growth, while a temporary M&A pause allows focus on deleveraging and integration. Management is highly optimistic about long-term prospects.
Fiscal Year 2024
-
Record 2024 results featured 11.6% revenue growth, 8.3% organic growth, and margin expansion, with strong cross-selling and customer retention. 2025 guidance projects continued organic growth, margin stability, and robust cash flow, supported by a strengthened balance sheet and new credit facility.
-
Record Q3 results featured 6.4% revenue growth and a 15.8% EBITDA margin, driven by strong organic growth and successful acquisitions. Guidance for 2024 was reaffirmed, with a focus on deleveraging and organic growth while temporarily pausing acquisitions.
-
Record Q2 and first-half results with 9% revenue and 10% adjusted EBITDA growth year-over-year, driven by strong organic growth and recent acquisitions. Guidance for 2024 is reiterated, with expectations for continued margin expansion and robust M&A activity.
-
The discussion highlighted that regulatory changes, including the Loper Bright ruling, are not expected to alter the business outlook or growth targets. Increased regulatory complexity and state-level authority are seen as opportunities, especially for advisory and testing services, with PFAS and methane remaining key growth drivers.